中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
上海药物研究所 [14]
合肥物质科学研究院 [12]
过程工程研究所 [1]
自动化研究所 [1]
采集方式
OAI收割 [28]
内容类型
期刊论文 [28]
发表日期
2022 [6]
2021 [3]
2020 [4]
2019 [4]
2018 [3]
2017 [2]
更多
学科主题
筛选
浏览/检索结果:
共28条,第1-10条
帮助
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
提交时间升序
提交时间降序
发表日期升序
发表日期降序
题名升序
题名降序
作者升序
作者降序
The reversal of anti-HER2 resistance in advanced HER2-positive breast cancer using apatinib: two cases reports and literature review
期刊论文
OAI收割
TRANSLATIONAL CANCER RESEARCH, 2022
作者:
He, Libin
;
Shen, Xiabo
;
Liu, Yiyuan
;
Gao, Lu
;
Wu, Jiayi
  |  
收藏
  |  
浏览/下载:23/0
  |  
提交时间:2022/12/23
Advanced human epidermal growth factor receptor 2-positive breast cancer (advanced HER2-positive breast cancer)
apatinib
case report
Multiple-dose up-titration study to evaluate the pharmacokinetics, safety and antitumor activity of apatinib in advanced gastric adenocarcinoma
期刊论文
OAI收割
FRONTIERS IN ONCOLOGY, 2022, 卷号: 12, 页码: 10
作者:
Wang, Yonggang
;
Wang, Chang
;
Zhang, Yanqiao
;
Hao, Jiqing
;
Yang, Nong
  |  
收藏
  |  
浏览/下载:25/0
  |  
提交时间:2022/12/13
apatinib
angiogenesis
gastric adenocarcinoma
pharmacokinetics
VEGFR
VEGFR-2
Apatinib combined with chemotherapy versus single chemotherapy in HER-2 negative advanced breast cancer: A randomized, controlled, open-label phase II study.
期刊论文
OAI收割
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:
Chen, Zhanhong
;
Wang, Xiaojia
;
Huang, Jian
;
Zheng, Yabing
;
Shao, Xiying
  |  
收藏
  |  
浏览/下载:23/0
  |  
提交时间:2022/12/23
Shape Designed Implanted Drug Delivery System for In Situ Hepatocellular Carcinoma Therapy
期刊论文
OAI收割
ACS NANO, 2022, 卷号: 16, 期号: 5, 页码: 8493-8503
作者:
Zhao, Chaochao
;
Shi, Qin
;
Li, Hu
;
Cui, Xi
;
Xi, Yuan
  |  
收藏
  |  
浏览/下载:20/0
  |  
提交时间:2023/02/24
hepatocellular carcinoma
self-powered
apatinib
triboelectric nanogenerator
drug delivery
Apatinib in patients with recurrent or metastatic thymic epithelial tumor: a single-arm, multicenter, open-label, phase II trial
期刊论文
OAI收割
BMC MEDICINE, 2022, 卷号: 20
作者:
Song, Zhengbo
;
Lou, Guangyuan
;
Wang, Yina
;
Yang, Zhiping
;
Wang, Wenxian
  |  
收藏
  |  
浏览/下载:21/0
  |  
提交时间:2022/12/23
Thymic epithelial tumors
Apatinib
Efficacy
Toxicities
Efficacy and safety of anlotinib with and without EGFR-TKIs or immunotherapy in the treatment of elder patients with non-small-cell lung cancer: a retrospective study
期刊论文
OAI收割
BMC PULMONARY MEDICINE, 2022, 卷号: 22
作者:
Wang, Wenxian
;
Shao, Lan
;
Xu, Yibing
;
Song, Zhengbo
;
Lou, Guangyuan
  |  
收藏
  |  
浏览/下载:22/0
  |  
提交时间:2022/12/23
Non-small cell lung cancer
Prognosis
Angiogenesis
Tyrosine kinase inhibitors
Apatinib vs Placebo in Patients With Locally Advanced or Metastatic, Radioactive Iodine-Refractory Differentiated Thyroid Cancer The REALITY Randomized Clinical Trial
期刊论文
OAI收割
JAMA ONCOLOGY, 2021
作者:
Lin, Yansong
;
Qin, Shukui
;
Li, Zhiyong
;
Yang, Hui
;
Fu, Wei
  |  
收藏
  |  
浏览/下载:63/0
  |  
提交时间:2022/01/25
Safety and efficacy of apatinib as third or later line treatment for advanced gastric cancer or gastroesophageal junction adenocarcinoma: A post-marketing phase IV study.
期刊论文
OAI收割
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:
Li, Jin
;
Qin, Shukui
;
Wen, Lu
;
Wang, Junsheng
;
Deng, Wenying
  |  
收藏
  |  
浏览/下载:25/0
  |  
提交时间:2022/01/10
Clinical effectiveness of apatinib at different doses in patients with advanced gastric cancer as the third-line or further treatment: Results from a post-marketing phase IV study.
期刊论文
OAI收割
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:
Li, Jin
;
Qin, Shukui
;
Wen, Lu
;
Wang, Junsheng
;
Deng, Wenying
  |  
收藏
  |  
浏览/下载:14/0
  |  
提交时间:2022/01/10
Apatinib in treating patients with recurrent or metastatic nasopharyngeal carcinoma who had failed prior platinum-based chemotherapy
期刊论文
OAI收割
TRANSLATIONAL CANCER RESEARCH, 2020, 卷号: 9
作者:
Tao, Chan-Juan
;
Zhang, Peng
;
Zhou, Ling
;
Hu, Qiao-Ying
;
Chen, Xiao-Zhong
  |  
收藏
  |  
浏览/下载:25/0
  |  
提交时间:2020/12/28
Apatinib
nasopharyngeal carcinoma (NPC)
recurrent or metastatic
platinum-based chemotherapy
toxicity